82 filings
8-K
BBLG
Bone Biologics Corp
15 Mar 24
Departure of Directors or Certain Officers
4:45pm
8-K
BBLG
Bone Biologics Corp
6 Mar 24
Bone Biologics Announces Pricing of $2.0 Million Public Offering
4:20pm
8-K
BBLG
Bone Biologics Corp
1 Mar 24
Bone Biologics Reports Progress with NB1 Clinical Program
8:05am
8-K
BBLG
Bone Biologics Corp
12 Jan 24
Other Events
5:15pm
8-K
BBLG
Bone Biologics Corp
11 Jan 24
Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors
8:15am
8-K
ees0 ay8dbw3p2mp
10 Jan 24
Other Events
8:15am
8-K
e5a l1wxual7h
2 Jan 24
Departure of Directors or Certain Officers
5:15pm
8-K
xev46aa t8yyv4p
18 Dec 23
Bone Biologics Announces 1-for-8 Reverse Stock Split
8:05am
8-K
rxh7 7lsv32sb
13 Dec 23
Submission of Matters to a Vote of Security Holders
9:15am
8-K
aitv599 p5gs
20 Nov 23
Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:46am
8-K
tuxkk9
24 Oct 23
Amendments to Articles of Incorporation or Bylaws
6:06am
8-K
snjncchpldg1
29 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:19pm
8-K
84yxb3j
12 Sep 23
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
o4qhsnm
5 Jul 23
Other Events
4:41pm
8-K
r03g0faal n3m
16 Jun 23
Bone Biologics Prices $5.0 Million Underwritten Public Offering
2:53pm
8-K
buh xysux
6 Jun 23
Amendments to Articles of Incorporation or Bylaws
1:14pm
8-K
twkazxu9a1h3 so
19 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:35pm
8-K
jlqmim
21 Dec 22
Departure of Directors or Certain Officers
4:54pm
8-K
riogqcj5vi80h0e34
21 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:29pm
8-K
ufh332
25 Oct 22
Bone Biologics CEO Issues Letter to Stockholders
9:49am